Pharmacia-ASPET Award for Impact on Pharmacological Treatment of Disease
Forecasted
Pharmacia-ASPET Award for Impact on Pharmacological Treatment of Disease honors scientists’ basic or clinical research with demonstrated or potential major impact on treating disease with drugs.
Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates (Anticipated): September 2027 (Nomination deadline)
Funding Amounts: Scientific achievement award rather than project funding
Summary: Recognizes outstanding basic or clinical research with demonstrated or potential major impact on the pharmacological treatment of disease.
Key Information: Scientists at any career stage may be nominated.
Description
The Pharmacia-ASPET Award for Impact on Pharmacological Treatment of Disease is administered by the American Society for Pharmacology and Experimental Therapeutics (ASPET) as part of its Scientific Achievement Awards. It recognizes and stimulates outstanding research in pharmacology and experimental therapeutics, including basic laboratory or clinical research that has had, or potentially will have, a major impact on the pharmacological treatment of disease.
The award falls within general pharmacology and recognizes scientific accomplishments rather than funding new research projects. It belongs to ASPET’s broader awards framework, which honors achievements in specific areas of pharmacology as well as contributions to the discipline generally.
